This content is only available within our institutional offering.
31 Jan 2019
LIBERUM: Roche - 2018 results beat as does guidance, 2-5% upgrades to consensus
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Roche - 2018 results beat as does guidance, 2-5% upgrades to consensus
- Published:
31 Jan 2019 -
Author:
Graham Doyle -
Pages:
4